Biocon shares jump 7% on strong Q4, dividend declaration
Biocon declared a dividend of ₹1.50 per share for FY23, which includes payout on account of one-time exceptional gains arising from partial monetisation of its holdings in Syngene
kiran mazumdar shaw 3
May 2023
March 2023
November 2022
October 2022
July 2022
February 2022
November 2021
October 2021
September 2021
Kiran Mazumdar-Shaw retires from Infosys board
The board of India's second-largest software services firm has appointed D. Sundaram as the lead independent director with effect from March 23.
Biocon Biologics completes acquisition of Viatris biosimilars biz for $3.3 bn
Biocon Biologics, Viatris get all key approvals from global regulators, including US FTC, CCI, RBI, and investors. Biocon Ltd’s stake in Biocon Biologics to rise to 68%.
Biocon stock tumbles 12% in 5 sessions; here’s why
Biocon shares declined as much as 2.4% to ₹262.40 on Wednesday, hitting its lowest level since November 2019.
HCL's Roshni Nadar Malhotra India’s richest woman; net worth ₹84,330 cr
Falguni Nayar of Nykaa is 2nd richest, with net worth of ₹57,520 cr; she’s also India's richest self-made woman, shows 'Leading Wealthy Women 2021' report by Hurun India, Kotak Private Banking
Bold bet! Biocon Biologics buys Viatris biosimilars assets for $3.33 billion
Viatris will receive $2 billion in cash and up to $335 million as additional payments expected to be paid in 2024.
Covid-19 put spotlight on vaccines, diagnostics: Mazumdar-Shaw
Resurgence of interest and new technologies bring a huge opportunity for the vaccine development field, says Biocon CMD Kiran Mazumdar-Shaw.
Walgreens to sell Biocon's insulin Semglee in the U.S.
Biocon Biologics targets to tap a $30 billion U.S. insulin market with two interchangeable insulins.
Biocon chief Kiran Mazumdar-Shaw denies 'Pandora Papers' charges
The 68-year-old Biocon chairperson retorted that information related to overseas entities were disclosed to regulatory agencies, and Kunal Kashyap's role is devoid of any legal authority.
VIDEO - Future is bio-pharma: Kiran Mazumdar-Shaw
Biocon's executive chairperson Dr Kiran Mazumdar Shaw, calls for a PLI scheme specially focused on incentivising biopharma investment.
